Non-steroidal anti-inflammatory drugs (NSAID)

Key figures
Data
Graphics
Comments

PRESCRIBERS
Main prescribers: General practitioners	71.89%
INSURED CONSUMERS
% of insured consumers	23.29%
Median age	50 years
Max/min ratio of the median age (by district)	1.06
Percentage of women	55.02%
Ratio Preferential scheme/General scheme	1.08
Coefficient of variation (2022)	10.92
Max/min ratio of % of insured consumers (by district)	1.55
CONSUMPTION
Annual consumption (DDD)	129,172,237
Consumption of DDD (per 100,000 insured persons)	1,122,368.23
% DDD issued outside the insurance (approximate)	30.72%
Average annual consumption per insured consumer (DDD)	48.19
% of insured consumers with > 3 times the average consumption	4,98%
Coefficient of variation 2013-2015	9.78
Coefficient of variation 2020-2022	18.35
Trend 2013-2022	-2.51%
Trend 2013-2019	-2.10%
Trend 2019-2022	-3.34%
DIRECT EXPENDITURE (DDD)
Annual expenditure charged to the insurance	36,147,667€
Average annual expenditure per insured person	3.14 €
Average patient share per insured consumer	13.90%
Max/min ratio of expenditure per insured person (by disctrict)	1.82
% “Low-cost” medication	85.19%
Trend 2013-2022	-4.62%
Trend 2019-2022	-4.98%

On this table, when a statistical test has been performed, the data showing a significant difference is displayed on an yellow background, otherwise on a grey background.

+ - ATC codes selected for analysis Click to collapse

CODES (ATC-5)	LABELS
M01AB	ACETIC ACID DERIVATIVES AND RELATED SUBSTANCES
M01AC	OXICAMS
M01AE	PROPIONIC ACID DERIVATIVES
M01AH	COXIBS
M01AX	OTHER ANTIINFLAMMATORY AND ANTIRHEUMATIC AGENTS, NON-STEROIDS